AngioDynamics ANGO Sales & Marketing
Sales & Marketing at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:SellingAndMarketingExpense.
The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about AngioDynamics's sales & marketing.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is AngioDynamics's sales & marketing?
- AngioDynamics (ANGO) reported sales & marketing of $27.44M in Q4 2025.
- How has AngioDynamics's sales & marketing changed year-over-year?
- AngioDynamics's sales & marketing increased by 7.6% year-over-year, from $25.5M to $27.44M.
- What is the long-term trend for AngioDynamics's sales & marketing?
- Over 4 years (2021 to 2025), AngioDynamics's sales & marketing has grown at a 6.1% compound annual growth rate (CAGR), from $81.31M to $103.14M.
- What does sales & marketing mean?
- Costs of selling products and services including sales force compensation, commissions, marketing campaigns, trade shows, and customer acquisition expenses.